Skip to content
← Full study record

NCT04119336 · MORE INFO

Limitations, agreements, and source contact

Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma · Source last updated 2023-08-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
AYEE1@mgh.harvard.edu
organization
Massachusetts General Hospital
phone
617-724-4000
title
Andrew Yee, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
AYEE1@mgh.harvard.edu
organization
Massachusetts General Hospital
phone
617-724-4000
title
Andrew Yee, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice